Silence Therapeutics Unaudited Preliminary Results 2011 - March 2012.
Featuring 2011 Highlights, an overview of Silence's performance and products, and an analysis of the commercial landscape of the field of RNAi.
Silence Therapeutics Unaudited Preliminary Results 2011 - March 2012.
Featuring 2011 Highlights, an overview of Silence's performance and products, and an analysis of the commercial landscape of the field of RNAi.
■ Hair Bang: 3 Types of Wave Length (650,660,630nm) / LLLT(Low Level Laser Therapy)
■ Hair Boom: 1 Type of Wave (660nm) / LLLT / CE,KFDA Certificates
■ Total 69 light (Hair Bang: 27 LD, 42 LED / Hair Boom: all 69 LD)
■ Laser mode / Vibration Mode
■ CE, KFDA, CFDA Certificates. FDA in progress.
Hair Bang(A.K.A Hair Boom) is a laser helmet for alopecia, hair loss treatment using LLLT technology which is approved by U.S FDA. Basically laser therapy is not dangerous and has no side effects compared to other treatment such as hair transplant, medication and so on. Hair Boom and Hair Bang product recovers scalp skin and capillary by using LLLT( Low Level Laser Therapy) stimulating blood flow circulation in head. Finally, this function deliveries oxygen and nutrients from activated capillary vessel to hair and eventually makes hair regrow and improves hair loss condition.
Visit us at: wtlaser.com
Keep up-to-date with the latest news from Haag-Streit UK by checking out our latest 'In Focus' newsletter. The newsletter contains all the most recent updates from both organisations, from product launches to events to special offers.
Littmann stethescope all models,littmann stethoscope buy online delhi/indiaSurgicals Shoppeseo
Skytech Medical is engaged in manufacturing and distribution of medical equipment and surgical instruments in India. The parent company Continental Surgical was established in 1954.An experienced and well-trained staff handles an extensive range of medical supplies, which can broadly be classified into the following categories :
Surgical Instruments and Equipments
Operating and Examination Tables and Lights
Stainless Steel Operating Room Furniture
Electro Medical Equipment used in Operating Room, Diagnostics, Imaging
Physiotherapy, Pathology Laboratories, Neonatology, Cardiac Care, etc.
Medical, Surgical and Laboratory Consumables
Powder Coated and Stainless Steel Hospital Furniture
Rehabilitation, Mobility and Personal Home Care Devices
Skytech Medical & Surgical Devices.
3617, Netaji Subhash Marg, Darya Ganj
New Delhi-110002, India
Tel:- 91-11-43528106
http://surgicalshoppe.co.in
surgicalshoppeseo@gmail.com
Insight into the 2024 ICD-10 PCS Updates - Part 2Health Catalyst
Prepare for mandatory ICD-10 PCS diagnosis code updates, which take effect on October 1, 2023. By attending this 60-minute educational session, medical coders and healthcare professionals will gain a comprehensive understanding of the changes to the 2024 ICD-10 procedure codes and their guidelines, enabling accurate and compliant coding for optimal billing and reimbursement.
Strategies for Device Approval in China, India, South Korea and AustraliaApril Bright
This session will describe the orthopaedic device regulatory and registration requirements in Asia Pacific markets. Regulatory steps and strategies will be presented for each of these countries. The discussion will also cover ways to gain regulatory information about competitors already selling in these markets. Attendees will leave the session with an understanding of timelines, costs and complexity for approval.
Impartial feasibility studies focused on Cefalotin manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/cefalotin-production-processes
REPORT: Competitive Intelligence Analysis on “Phacoemulsification Device” by ...Caroline Charumathy
This Competitive Intelligence Report by DexPatent gives you a thorough and comprehensive analysis of all patents published, granted or expired by companies, start-ups, inventors or universities across the world during 01 - 15 Feb 2019. This Exclusive report provides you patent and technology insights which help you to take direct decisions relating to R&D alignment, licensing or acquisition and saves a lot of time of your in-house IP and R&D team.
To get in-depth analysis of innovations and opportunities relating to Fingerprint detection in portable devices, Please contact us at linda@dexpatent.com.
The report helps you to understand the gist of each important patent just by a glance.
OxySure Systems Inc. is a medical technology company focused on the design, manufacture and distribution of specialty respiratory and medical solutions. The Company has developed a unique platform technology, whereby medically pure oxygen is created instantly from two dry, inert powders, allowing oxygen to be delivered on demand. The launch product using this technology is called the OxySure Model 615.With Model 615, there are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the technology is both safe and easy-to-use for the layperson. Similar to an automated external defibrillator (AED) or fire extinguisher, it can be placed just about anywhere a medical emergency might occur to help improve medical outcomes and save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.
Techno-economic analyses of specific BTX production processes, presenting capital investment breakdown, raw materials consumed and operating costs. Know more at www.intratec.us/products/btx-production-processes
Impartial feasibility studies focused on Dibutyl Ketone manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/dibutyl-ketone-production-processes
Impartial feasibility studies focused on Caffeine manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/caffeine-production-processes
Techno-economic analyses of specific Octenes production processes, presenting capital investment breakdown, raw materials consumed and operating costs.
Know more at www.intratec.us/products/octenes-production-processes
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
Cracking the Workplace Discipline Code Main.pptxWorkforce Group
Cultivating and maintaining discipline within teams is a critical differentiator for successful organisations.
Forward-thinking leaders and business managers understand the impact that discipline has on organisational success. A disciplined workforce operates with clarity, focus, and a shared understanding of expectations, ultimately driving better results, optimising productivity, and facilitating seamless collaboration.
Although discipline is not a one-size-fits-all approach, it can help create a work environment that encourages personal growth and accountability rather than solely relying on punitive measures.
In this deck, you will learn the significance of workplace discipline for organisational success. You’ll also learn
• Four (4) workplace discipline methods you should consider
• The best and most practical approach to implementing workplace discipline.
• Three (3) key tips to maintain a disciplined workplace.
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
■ Hair Bang: 3 Types of Wave Length (650,660,630nm) / LLLT(Low Level Laser Therapy)
■ Hair Boom: 1 Type of Wave (660nm) / LLLT / CE,KFDA Certificates
■ Total 69 light (Hair Bang: 27 LD, 42 LED / Hair Boom: all 69 LD)
■ Laser mode / Vibration Mode
■ CE, KFDA, CFDA Certificates. FDA in progress.
Hair Bang(A.K.A Hair Boom) is a laser helmet for alopecia, hair loss treatment using LLLT technology which is approved by U.S FDA. Basically laser therapy is not dangerous and has no side effects compared to other treatment such as hair transplant, medication and so on. Hair Boom and Hair Bang product recovers scalp skin and capillary by using LLLT( Low Level Laser Therapy) stimulating blood flow circulation in head. Finally, this function deliveries oxygen and nutrients from activated capillary vessel to hair and eventually makes hair regrow and improves hair loss condition.
Visit us at: wtlaser.com
Keep up-to-date with the latest news from Haag-Streit UK by checking out our latest 'In Focus' newsletter. The newsletter contains all the most recent updates from both organisations, from product launches to events to special offers.
Littmann stethescope all models,littmann stethoscope buy online delhi/indiaSurgicals Shoppeseo
Skytech Medical is engaged in manufacturing and distribution of medical equipment and surgical instruments in India. The parent company Continental Surgical was established in 1954.An experienced and well-trained staff handles an extensive range of medical supplies, which can broadly be classified into the following categories :
Surgical Instruments and Equipments
Operating and Examination Tables and Lights
Stainless Steel Operating Room Furniture
Electro Medical Equipment used in Operating Room, Diagnostics, Imaging
Physiotherapy, Pathology Laboratories, Neonatology, Cardiac Care, etc.
Medical, Surgical and Laboratory Consumables
Powder Coated and Stainless Steel Hospital Furniture
Rehabilitation, Mobility and Personal Home Care Devices
Skytech Medical & Surgical Devices.
3617, Netaji Subhash Marg, Darya Ganj
New Delhi-110002, India
Tel:- 91-11-43528106
http://surgicalshoppe.co.in
surgicalshoppeseo@gmail.com
Insight into the 2024 ICD-10 PCS Updates - Part 2Health Catalyst
Prepare for mandatory ICD-10 PCS diagnosis code updates, which take effect on October 1, 2023. By attending this 60-minute educational session, medical coders and healthcare professionals will gain a comprehensive understanding of the changes to the 2024 ICD-10 procedure codes and their guidelines, enabling accurate and compliant coding for optimal billing and reimbursement.
Strategies for Device Approval in China, India, South Korea and AustraliaApril Bright
This session will describe the orthopaedic device regulatory and registration requirements in Asia Pacific markets. Regulatory steps and strategies will be presented for each of these countries. The discussion will also cover ways to gain regulatory information about competitors already selling in these markets. Attendees will leave the session with an understanding of timelines, costs and complexity for approval.
Impartial feasibility studies focused on Cefalotin manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/cefalotin-production-processes
REPORT: Competitive Intelligence Analysis on “Phacoemulsification Device” by ...Caroline Charumathy
This Competitive Intelligence Report by DexPatent gives you a thorough and comprehensive analysis of all patents published, granted or expired by companies, start-ups, inventors or universities across the world during 01 - 15 Feb 2019. This Exclusive report provides you patent and technology insights which help you to take direct decisions relating to R&D alignment, licensing or acquisition and saves a lot of time of your in-house IP and R&D team.
To get in-depth analysis of innovations and opportunities relating to Fingerprint detection in portable devices, Please contact us at linda@dexpatent.com.
The report helps you to understand the gist of each important patent just by a glance.
OxySure Systems Inc. is a medical technology company focused on the design, manufacture and distribution of specialty respiratory and medical solutions. The Company has developed a unique platform technology, whereby medically pure oxygen is created instantly from two dry, inert powders, allowing oxygen to be delivered on demand. The launch product using this technology is called the OxySure Model 615.With Model 615, there are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the technology is both safe and easy-to-use for the layperson. Similar to an automated external defibrillator (AED) or fire extinguisher, it can be placed just about anywhere a medical emergency might occur to help improve medical outcomes and save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.
Techno-economic analyses of specific BTX production processes, presenting capital investment breakdown, raw materials consumed and operating costs. Know more at www.intratec.us/products/btx-production-processes
Impartial feasibility studies focused on Dibutyl Ketone manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/dibutyl-ketone-production-processes
Impartial feasibility studies focused on Caffeine manufacturing economics, showing CAPEX, OPEX, key process indicators and process diagrams. Know more at www.intratec.us/products/caffeine-production-processes
Techno-economic analyses of specific Octenes production processes, presenting capital investment breakdown, raw materials consumed and operating costs.
Know more at www.intratec.us/products/octenes-production-processes
Similar to Aestus Non Confidential Intro 062410 (18)
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
Cracking the Workplace Discipline Code Main.pptxWorkforce Group
Cultivating and maintaining discipline within teams is a critical differentiator for successful organisations.
Forward-thinking leaders and business managers understand the impact that discipline has on organisational success. A disciplined workforce operates with clarity, focus, and a shared understanding of expectations, ultimately driving better results, optimising productivity, and facilitating seamless collaboration.
Although discipline is not a one-size-fits-all approach, it can help create a work environment that encourages personal growth and accountability rather than solely relying on punitive measures.
In this deck, you will learn the significance of workplace discipline for organisational success. You’ll also learn
• Four (4) workplace discipline methods you should consider
• The best and most practical approach to implementing workplace discipline.
• Three (3) key tips to maintain a disciplined workplace.
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
Kseniya Leshchenko: Shared development support service model as the way to ma...Lviv Startup Club
Kseniya Leshchenko: Shared development support service model as the way to make small projects with small budgets profitable for the company (UA)
Kyiv PMDay 2024 Summer
Website – www.pmday.org
Youtube – https://www.youtube.com/startuplviv
FB – https://www.facebook.com/pmdayconference
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Enterprise Excellence is Inclusive Excellence.pdfKaiNexus
Enterprise excellence and inclusive excellence are closely linked, and real-world challenges have shown that both are essential to the success of any organization. To achieve enterprise excellence, organizations must focus on improving their operations and processes while creating an inclusive environment that engages everyone. In this interactive session, the facilitator will highlight commonly established business practices and how they limit our ability to engage everyone every day. More importantly, though, participants will likely gain increased awareness of what we can do differently to maximize enterprise excellence through deliberate inclusion.
What is Enterprise Excellence?
Enterprise Excellence is a holistic approach that's aimed at achieving world-class performance across all aspects of the organization.
What might I learn?
A way to engage all in creating Inclusive Excellence. Lessons from the US military and their parallels to the story of Harry Potter. How belt systems and CI teams can destroy inclusive practices. How leadership language invites people to the party. There are three things leaders can do to engage everyone every day: maximizing psychological safety to create environments where folks learn, contribute, and challenge the status quo.
Who might benefit? Anyone and everyone leading folks from the shop floor to top floor.
Dr. William Harvey is a seasoned Operations Leader with extensive experience in chemical processing, manufacturing, and operations management. At Michelman, he currently oversees multiple sites, leading teams in strategic planning and coaching/practicing continuous improvement. William is set to start his eighth year of teaching at the University of Cincinnati where he teaches marketing, finance, and management. William holds various certifications in change management, quality, leadership, operational excellence, team building, and DiSC, among others.
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
🟢 Email Access
🟢 Bank Added
🟢 Card Verified
🟢 Full SSN Provided
🟢 Phone Number Access
🟢 Driving License Copy
🟢 Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1(218) 203-5951
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
2. Aestus Therapeutics Inc
Founded in 2005, Aestus is a translational medicine company
focused on the accelerated development of first-in-class
therapeutics for nervous system disorders
The Aestus key proprietary element is our unique systems
biology engine to discover novel targets for the diseases of
interest
Aestus validates these targets using compounds developed for
other indications
Aestus opportunistically in-licenses active compounds from this
target validation for Phase 2 clinical studies
2
3. Management
Tage Honore, President & CEO:
Previously, Vice President at Novo Nordisk, Novartis, and
Purdue Pharma.
Brought more than 35 new drug concepts to early clinical
studies in multiple disease conditions, of which three were
launched.
Managed budgets for a total of $1B, achieving record pipeline
productivity in several companies.
Ph D. in Medicinal Chemistry and Doctor of Science in
Neurobiology from the Royal Danish School of Pharmacy in
Denmark. Business training from European Management Centre
and Harvard Business School.
3
4. Management, cont
F. Aaron Dubberley, Director of Intellectual Property:
Previously, McAulay Nissen Goldberg Kiel & Hand (now the New
York IP group for Reed Smith), Hoffmann-La Roche, Aventis and
senior U.S. patent attorney at Organon International.
Thirteen years of pharma IP experience, including all aspects of
patent acquisition, freedom-to-operate, IP due diligence and
licensing.
MS. in Biochemistry and Molecular Biology from University of
California, Davis, and JD. from Rutgers.
4
5. Management, cont
Dan Lavery, Director, Research and Genomics:
Previously, Director, Molecular Biology, Chromocell
Corporation, research and management positions at Glaxo
SmithKline and Purdue Pharma
Twenty years of experience in differential gene expression,
target ID & validation
Managed $36 million multi-year research collaboration on
molecular biology of taste
BA, Johns Hopkins University and PhD., Mt. Sinai Medical
School/NYU. Post-doctoral researcher and Lecturer, University
of Geneva, Switzerland.
5
6. Status Update
Our most advanced product, ATx08-001, enters clinical phase 2
proof of efficacy studies this quarter for treatment of post-
herpetic neuralgia (PHN) as a first-in-class novel pain
therapeutic.
These studies are funded by a non-dilutive SBIR grant totaling
$2.6 million from NIH.
6
7. Investment Proposition
Aestus is seeking capital to expand our portfolio of products for
neuropathic pain in addition to the current phase 2 pain trial of
ATx08-001.
Proceeds will be used to progress two additional products in
neuropathic pain, ATx09-002 and ATx03-005, which act at
different targets than ATx08-001, in proof-of-concept phase 2
trials on PHN.
Proceeds will also fund pre-clinical and clinical studies on
treatments for schizophrenia and ALS, over the next 2-5 years.
Revenue will be created by sub-license to or collaboration with
pharma in late stage clinical studies, NDA and product launch.
7
Near-term value milestones identified.
8. The Aestus Pipeline
Pre-clinical Patent filing, Clinical Proof-
Project Data analysis Compound ID validation in-licensing of-efficacy
Neuropathic ATx08-001, ATx09-002, ATx03-005
pain
ALS
(Lou Gehrig’s 4 compounds
disease)
Schizophrenia 30 compounds
Epilepsy
Other disease
areas
~ 1 year ~ 1 year ~ 1.5 – 2 years
8
9. Clinical trial compounds
All three compounds showed robust performance in universally accepted pre-clinical
models of neuropathic pain (Chung, Bennett); excellent safety profile and no serious
adverse events in phase 1 and 2 clinical studies for original indications.
ATx08-001:
• MW: 468.4
• PPAR gamma agonist
• Aestus: Initiating phase 2 trials in PHN this quarter
ATx09-002:
• MW: 481.36
• Glycogen phosphorylase inhibitor
• Aestus: in-license term sheet negotiated
ATx03-005:
• MW 500.54
• Fructose 1,6-bisphosphatase inhibitor
• Aestus: in-license term sheet negotiated
9
10. Investment and Value Creation
$10M investment:
Clinical Phase 2 proof of efficacy of two products (ATx09-002, ATx03-005) for
post-herpetic neuralgia
• Third product, ATx08-001, now beginning Phase 2 clinical trials for PHN,
financed by non-dilutive SBIR grant
Value creation steps:
Out-license of product(s) after successful Phase 2a pain trial (2-3 years)
Partnering for full development of product after successful Phase 2 trials (3+
years)
Acquisition, trade sale or IPO of Aestus (5+ years)
10
11. Five Year Budget
Aestus Therapeutics Inc Five–year Financial Plan (all values in $)
2010 2011 2012 2013 2014
Revenue
SBIR phase 2 grant 1,500,000 1,500,000 0 0 0
Milestone payments to Aestus for ATx08-001 0 0 30,000,000 0 25,000,000
Milestone payments to Aestus for ATx09-002 0 0 30,000,000 0 25,000,000
Milestone payments to Aestus for ATx-Schizo 0 0 0 30,000,000 0
Total Revenue 1,500,000 1,500,000 50,000,000 30,000,000 50,000,000
Product cost
In-license payment for ATx08-001 1,000,000 0 0 0 0
Milestone payment for ATx08-001 0 0 5,000,000 0 5,000,000
In-license payment for ATx09-002 1,000,000 0 0 0 0
Milestone payment for ATx09-002 0 0 15,000,000 12,500,000
In-license payment for ATx-Schizo 0 1,000,000 0 0
Milestone payment for ATx-Schizo 5,000,000 0
Total product cost 2,000,000 1,000,000 20,000,000 5,000,000 17,500,000
Operating expenses
Clinical development costs 3,000,000 4,500,000 1,500,000 0 0
Research to expand portfolio, salaries/
benefits, infrastructure
1,400,000 1,400,000 1,400,000 1,400,000 1,400,000
Total operating expenses 4,400,000 5,900,000 2,900,000 1,400,000 1,400,000
EBIT -4,900,000 -5,400,000 37,100,000 23,600,000 31,100,000
Projections based on terms of comparable pharma license agreements, and assuming successful clinical development and partnering
11 of three Aestus products.
= milestone payment for entry into Phase 3 trials = milestone payment for NDA filing
12. Investment summary
Reduced risk in PHN Phase 2 clinical trials
Exclusive WW license from COM owner in place
Managed by a high-calibre, highly experienced team of industry
executives
Extensive use of out-sourcing to keep burn rate low
Potential sub-licensees already identified and awaiting data
An attractive, balanced portfolio
12
13. ATx In-license and IP Status
Products
ATx09-002 ATx08-001 ATx03-005
In-license status Agreed Signed Negotiating
License scope Exclusive Exclusive Exclusive
Field NP Human therapy NP-DN
Territory Worldwide Worldwide Worldwide
Patent life
Composition of matter
patent (issued) 2024* 2016* 2019*
Use patent (application) 2027* 2030* 2027*
* = Plus data exclusivity and any available patent term extension
NP = Neuropathic pain
DN = Diabetic neuropathy
13
15. The Aestus Engine
1. Aestus-proprietary disease-relevant genomics databases 2. Aestus-proprietary data QC,
• Also leverage public genomics databases (GEO, EBI) statistical meta-analysis across
multiple datasets
c
a
b
4. Mapping of gene clusters to biological pathways: 3. Aestus-proprietary
a) Known pathways – validate analysis biologically-informed cluster
b) Novel pathways – may be of value for discovery analysis
c) Aestus-proprietary novel association of disease to
15 well-studied pathways
16. The Aestus Engine
4. Mapping of gene clusters to biological pathways:
c) Aestus-proprietary novel association of
disease to well-studied pathways
5. Identify Phase 1+ compounds 6. Validate novel pathways using Phase 1+ compounds in
acting at these pathways, pre-clinical disease models (e.g., pain models above)
developed for other indications - Aestus-proprietary use patents (e.g., Aestus
patent application US2010/0076037)
- In-license for Phase 2 clinical development
16
17. Aestus Discovery & Development Model
Identify novel disease targets through the proprietary Aestus
engine for systems biology data-mining
Identify de-risked compounds (Phase 2-ready) developed for
other indications, acting at our targets
Validate pathways with these compounds in pre-clinical animal
models
Patent active compounds for novel utility (Aestus IP)
Obtain exclusive worldwide license from composition
of matter owner
Show proof of efficacy in clinical phase 2 trial
Co-develop/out-license with pharma partner for later-stage
17
development
19. Aestus Platform vs. Compound Reprofiling
Aestus has succeeded where compound reprofiling failed:
Using Aestus platform, several novel pain targets were identified
and validated with compounds acting at these targets
Aestus approached the composition of matter owner of one
compound to negotiate in-licensing agreement for clinical
development as pain product
Owner had already engaged a major compound reprofiler to
identify other appropriate indications
Six months later and after failure to identify novel indications by
reprofiler, owner contacted Aestus to negotiate our proposal
19
20. Third Party Validation
Pain Research collaboration
– (Public traded pharmaceutical company, (name withheld))
Small Business Innovation Research Grants
– Phase I and Phase II (National Institute of Neurological Disorders and
Stroke (NINDS))
– $2.6 million non-dilutive funding for Phase 2 clinical trial of Aestus pain
product ATx08-001, initiated this year
Edison Innovation Research and Development Grant
– (New Jersey Commission on Science and Technology (NJCST))
– $500K non-dilutive funding
License partners
– (Four publicly traded Pharmaceutical companies,
20 (names withheld))
21. Intellectual Property
Three provisional and three non-provisional PCT
applications filed, including:
– WO2008/057930A2
– WO2008/057933A2
– WO2008/063842A2
– US 2010/0076037
21
22. Infrastructure
Located in Commercialization Centre for Innovative Technologies,
New Brunswick, NJ
• Cost effective, state supported, located on US Highway 1
5 full time employees on payroll:
• Tage Honore, President & CEO
• Aaron Dubberley, Director Intellectual Properties
• Daniel Lavery, Director Research & Genomics
• Meredith Prysak, Project management
• Kathy Kerrigan, Administrative Assistant
3 further employees to be employed in the future:
• VP Commercial
• Director Informatics
• VP Clinical
All others are advisors and consultants
22
25. ATx08-001 in chronic pain model
ATx08-001 reverses pain behavior (cold allodynia) in rats in the Bennett chronic
constriction model of neuropathic pain. Reversal of pain behavior by ATx08-001 was
equal to or greater than equivalent doses of the positive control pain medication,
carbamazepine. Error bars, SEM; * = p < 0.05 compared to vehicle.
25
26. ATx09-002 in chronic pain model (I)
ATx09-002 reverses pain behavior (cold allodynia) in rats in the Bennett chronic
constriction model in a dose-dependent manner. Reversal of pain behavior by ATx09-
002 at 100 mg/kg was equal to that of 100 mg/kg carbamazepine, the positive control. Error
bars = SEM; * = p < 0.05 versus vehicle.
26
27. ATx09-002 in chronic pain model (II)
ATx09-002 reverses pain behavior (mechanical allodynia) in rats in the Chung spinal
nerve ligation model of neuropathic pain. Reversal of pain behavior by ATx09-002 (30
mg/kg) was greater than that by greater doses of the positive control pain medication,
carbamazepine (100 mg/kg; * = p < 0.05, ATx09-002 vs. carbamazepine; error bars = SEM).
27